Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Devos

Showing results (171-180 of 220) with videos related to

Pageof 22
Sort By:
Scientific Reports|March 1, 2019
A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral SclerosisDavid Devos, Caroline Moreau, Maeva Kyheng, et al.
Brain : a Journal of Neurology|April 2, 2008
Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairmentSophie Tezenas du Montcel, Perrine Charles, Pascale Ribai, et al.
Scientific Reports|February 21, 2020
Author Correction: A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral SclerosisDavid Devos, Caroline Moreau, Maeva Kyheng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2011
Quantitative assessment of the evolution of cerebellar signs in spinocerebellar ataxiasEllis Chan, Perrine Charles, Pascale Ribai, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 29, 2021
Assessing the upper motor neuron in amyotrophic lateral sclerosis using the triple stimulation technique: A multicenter prospective studyAude-Marie Grapperon, Annie Verschueren, Elisabeth Jouve, et al.
The Lancet. Neurology|January 22, 2022
Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trialGiulia Coarelli, Anna Heinzmann, Claire Ewenczyk, et al.
Journal of Neurology|April 1, 2025
Natural history of adult-onset metachromatic leukodystrophyDaniele Mandia, Juliette Dufour, Silvia Fenu, et al.
Scientific Reports|June 4, 2026
Body placement of inertial measurement units differentially affects physical activity assessment accuracy in drug-naïve Parkinson's diseaseCorina Maetzler, Masoud Abedinifar, Vaishali Vinod, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2024
Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA TrialChristine Brefel-Courbon, Estelle Harroch, Ana Marques, et al.
Parkinsonism & Related Disorders|August 6, 2025
Non-motor subtypes in candidates for subthalamic deep brain stimulation for Parkinson's diseaseHélène Ducrocq, Salomé Puisieux, Lucie Hopes, et al.
Pageof 22

Showing results (171-180 of 220) with videos related to

Sort By:
Pageof 22
Scientific Reports|March 1, 2019
A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral SclerosisDavid Devos, Caroline Moreau, Maeva Kyheng, et al.
Brain : a Journal of Neurology|April 2, 2008
Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairmentSophie Tezenas du Montcel, Perrine Charles, Pascale Ribai, et al.
Scientific Reports|February 21, 2020
Author Correction: A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral SclerosisDavid Devos, Caroline Moreau, Maeva Kyheng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2011
Quantitative assessment of the evolution of cerebellar signs in spinocerebellar ataxiasEllis Chan, Perrine Charles, Pascale Ribai, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 29, 2021
Assessing the upper motor neuron in amyotrophic lateral sclerosis using the triple stimulation technique: A multicenter prospective studyAude-Marie Grapperon, Annie Verschueren, Elisabeth Jouve, et al.
The Lancet. Neurology|January 22, 2022
Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trialGiulia Coarelli, Anna Heinzmann, Claire Ewenczyk, et al.
Journal of Neurology|April 1, 2025
Natural history of adult-onset metachromatic leukodystrophyDaniele Mandia, Juliette Dufour, Silvia Fenu, et al.
Scientific Reports|June 4, 2026
Body placement of inertial measurement units differentially affects physical activity assessment accuracy in drug-naïve Parkinson's diseaseCorina Maetzler, Masoud Abedinifar, Vaishali Vinod, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2024
Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA TrialChristine Brefel-Courbon, Estelle Harroch, Ana Marques, et al.
Parkinsonism & Related Disorders|August 6, 2025
Non-motor subtypes in candidates for subthalamic deep brain stimulation for Parkinson's diseaseHélène Ducrocq, Salomé Puisieux, Lucie Hopes, et al.
Pageof 22